Dechra Pharmaceuticals (DPH)

Company name:Dechra Pharmaceuticals Plc
EPIC:DPHTrading Currency:GBX
Market Sector:F25FISIN:GB0009633180
Market Segment:STMMShare Type:DE
WWW Address:http://www.dechra.com/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 2,796.00 images.advfn.com/imagesnew/2/gb/up 10.0 [0.36] 2,792.00 2,794.00 2,798.00 2,816.00 2,782.00 153,192
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 2,870.14 102.65 2.04 30.15 31.60 92.74 1.13 3,081.00 - 2,020.00

Dechra Pharmaceuticals Key Figures

(at previous day's close)
Market Cap.2,870.14m
Shares In Issue102.65m
Prev. Close2,786.00
PE Ratio92.74 
Dividend Yield1.13%
EPS - basic30.15p
Dividend PS31.60p
Dividend Cover0.95 
Cash Flow PS79.69p
Return On Equity (ROE)6.07%
Operating Margin5.77%
PEG Factor-4.87 
EPS Growth Rate-19.04%
Dividends PS Growth Rate23.92%
Net Debt459.10m
Gross Gearing51.44%
Quick Assets189.00m
Net Working Capital174.90m
Intangibles / Fixed Assets90.93%
Turnover PS469.35p
Pre-Tax Profit PS27.08p
Retained Profit PS2.44p
Cash PS78.23p
Net Cash PS-36.82p
Net Tangible Asset Value PS *-173.30p
Net Asset Value PS495.95p
Spread2.00 (0.07%) 

Dechra Pharmaceuticals Balance Sheet

DPH:Liabilities+EQDPH:Assets

Share Price Performance

Sample Period HighLow
1 week2,856.002,730.00
4 weeks2,856.002,592.00
12 weeks2,980.002,516.00
1 year3,081.002,020.00

Share Price Chart (5 years)

Dechra Pharmaceuticals Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week2,822.00-26.00-0.922,730.000.162,775.84
4 weeks2,628.00168.006.392,592.000.232,745.48
12 weeks2,868.00-72.00-2.512,516.000.302,694.96
26 weeks2,732.0064.002.342,516.000.252,773.66
1 year2,162.00634.0029.322,020.000.252,619.89
3 years1,243.001,553.00124.941,225.000.252,350.89
5 years794.502,001.50251.92774.000.202,030.50

Dechra Pharmaceuticals Key Management Ratios

Dechra Pharmaceuticals Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio129.98 
PE Ratio92.74 
Tobin's Q Ratio 2.78 
Tobin's Q Ratio (excl. intangibles)8.58 
Dividend Yield1.13%
Market-to-Book Ratio5.64 
Price-to-Pre-Tax Profit PS103.24 
Price-to-Retained Profit PS1,148.06 
Price-to-Cash Flow PS35.09 
Price-to-Sales PS5.96 
Price-to-Net Tangible Asset Value PS-16.13 
Price-to-Cash PS35.74 
Net Working Capital PS170.38 
Price Pct to Working Capital PS16.41%
Earnings Yield1.08%
Average PE70.88 
Years in average5 
PE to PE average130.83%

Dechra Pharmaceuticals Financial Ratios

(Leverage Ratios)
Debt Ratio45.28%
Debt-to-Equity Ratio0.83 
Debt-to-Equity Ratio (excl. Intgbl)-2.37 
Debt-to-Equity Market Value0.15 
Net Gearing43.79%
Net Gearing (excl. Intangibles)127.00%
Gross Gearing51.44%
Gross Gearing (excl. Intangibles)149.21%
Gearing Under 1 Year11.26%
Gearing Under 1 Year (excl. Intgbl)32.67%
Assets/Equity2.06 
Cash/Equity15.77 
(Liquidity Ratios)
Net Working Capital to Total Assets16.68%
Current Ratio2.48 
Quick Ratio (Acid Test)1.60 
Liquidity Ratio0.68 
Cash & Equiv/Current Assets27.41%
(Solvency Ratios)
Enterprise Value3,211.14m
CFO/Sales0.17 
CFO/Attributable Profit2.65 
CFO/Assets0.08 
CFO/Debt0.15 
Total Debt/Equity Market Value0.19 
Total Debt/Sales1.12 
Total Debt/Pre-Tax Profit19.40 
Total Debt539.40m
Total Debt/Net Current Assets3.08%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth2.39%
5 yr Compound Earnings Growth6.37%
10 yr Compound Earnings Growth4.21%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)
2.04151.1784

Dechra Pharmaceuticals Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)2.99%
Return On Assets (ROA)2.99%
Net Profit Margin6.41%
Assets Turnover0.47 
Return On Equity (ROE)6.07%
Return On Investment (ROI)3.33%
Dividend Payout Ratio104.81%
Plowback Ratio-4.81%
Growth from Plowback Ratio-0.29%
Net Income Of Revenues0.52%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.95 
Fixed Assets Turnover0.63 
Current Assets Turnover1.77 
Net Working Capital Turnover 
Inventory Turnover5.06 
(Other Operating Ratios)
Total Assets-to-Sales2.14 
Debtors-to-Sales20.14%
Debt Collection Period73.52Days

Dechra Pharmaceuticals Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
02 Sep 2019FinalGBX22.1030/06/201830/06/201924/10/201925/10/201915/11/201931.60
25 Feb 2019InterimGBX9.5030/06/201830/06/201907/03/201908/03/201908/04/2019-
03 Sep 2018FinalGBX18.1730/06/201730/06/201825/10/201826/10/201816/11/201825.50
26 Feb 2018InterimGBX7.3330/06/201730/06/201808/03/201809/03/201806/04/2018-
04 Sep 2017FinalGBX15.3330/06/201630/06/201726/10/201727/10/201717/11/201721.44
27 Feb 2017InterimGBX6.1130/06/201630/06/201709/03/201710/03/201707/04/2017-
05 Sep 2016FinalGBX12.9130/06/201530/06/201627/10/201628/10/201618/11/201618.46
22 Feb 2016InterimGBX5.5530/06/201530/06/201610/03/201611/03/201606/04/2016-
07 Sep 2015FinalGBX11.8230/06/201430/06/201529/10/201530/10/201520/11/201516.94
23 Feb 2015InterimGBX5.1230/06/201430/06/201512/03/201513/03/201507/04/2015-
08 Sep 2014FinalGBX10.6530/06/201330/06/201406/11/201407/11/201421/11/201415.40
25 Feb 2014InterimGBX4.7530/06/201330/06/201412/03/201414/03/201408/04/2014-
03 Sep 2013FinalGBX9.6630/06/201230/06/201306/11/201308/11/201322/11/201314.00
26 Feb 2013InterimGBX4.3430/06/201230/06/201313/03/201315/03/201309/04/2013-
04 Sep 2012FinalGBX8.5030/06/201130/06/201207/11/201209/11/201223/11/201212.60
21 Feb 2012InterimGBX4.1030/06/201130/06/201207/03/201209/03/201210/04/2012-
06 Sep 2011FinalGBX8.4030/06/201030/06/201109/11/201111/11/201125/11/201112.10
22 Feb 2011InterimGBX3.7030/06/201030/06/201109/03/201111/03/201107/04/2011-
07 Sep 2010FinalGBX7.2030/06/200930/06/201010/11/201012/11/201010/12/201010.50
23 Feb 2010InterimGBX3.3030/06/200930/06/201003/03/201005/03/201001/04/2010-
01 Sep 2009FinalGBX6.1030/06/200830/06/200911/11/200913/11/200911/12/20099.10
02 Sep 2008FinalGBX2.7530/06/200730/06/200812/11/200814/11/200812/12/2008-
25 Feb 2007InterimGBX2.5001/07/200631/12/200607/03/200709/03/200710/04/2007-
05 Sep 2006FinalGBX4.3330/06/200530/06/200625/10/200627/10/200624/11/20066.24
28 Feb 2006InterimGBX1.9101/07/200531/12/200508/03/200610/03/200607/04/2006-
06 Sep 2005FinalGBX3.5030/06/200430/06/200526/10/200528/10/200525/11/20055.20
01 Mar 2005InterimGBX1.7001/07/200431/12/200409/03/200511/03/200507/04/2005-
07 Sep 2004FinalGBX3.1530/06/200330/06/200427/10/200429/10/200424/11/20044.70
02 Mar 2004InterimGBX1.5501/07/200331/12/200310/03/200412/03/200407/04/2004-
02 Sep 2003FinalGBX2.7530/06/200230/06/200329/10/200331/10/200326/11/20034.12
04 Mar 2003InterimGBX1.3701/07/200231/12/200212/03/200314/03/200309/04/2003-
03 Sep 2002FinalGBX2.7530/06/200130/06/200229/10/200201/11/200227/11/20024.12
26 Feb 2002InterimGBX1.3701/07/200131/12/200106/03/200208/03/200208/04/2002-
04 Sep 2001FinalGBX2.5030/06/200030/06/200131/10/200102/11/200128/11/20013.75
28 Feb 2001InterimGBX1.2501/07/200031/12/200007/03/200109/03/200104/04/2001-

Dechra Pharmaceuticals Fundamentals

 30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
turnover247.56100.00%359.28100.00%407.10100.00%481.80100.00%m
pre tax profit14.555.88%28.567.95%28.907.10%27.805.77%m
attributable profit12.675.12%26.117.27%36.108.87%30.906.41%m
retained profit-2.62-1.06%8.442.35%14.303.51%2.500.52%m
eps - basic (p)14.00 28.09 37.24 30.15 
eps - diluted (p)13.90 27.93 37.04 30.07 
dividends per share18.46 21.44 25.50 31.60 

Dechra Pharmaceuticals Balance Sheet

 30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
DPH:Liabilities+EQDPH:AssetsDPH:Liabilities+EQDPH:AssetsDPH:Liabilities+EQDPH:AssetsDPH:Liabilities+EQDPH:Assets
 30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
ASSETS
fixed assets fixed assets37.726.73%45.207.08%45.304.45%58.405.57%m
intangibles intangibles360.3864.27%396.2662.10%709.8069.77%687.0065.52%m
fixed investments fixed investments--%10.851.70%10.501.03%10.100.96%m
current assets - other current assets - other--%--%--%--%m
stocks stocks54.389.70%56.518.86%86.608.51%104.009.92%m
debtors debtors69.1412.33%68.0510.66%85.408.39%108.7010.37%m
cash & securities cash & securities39.146.98%61.209.59%79.707.83%80.307.66%m
TOTAL560.75100%638.07100%1,017.30100%1,048.50100%m
LIABILITIES
creditors - short creditors - short66.2611.82%66.4110.41%91.609.00%118.1011.26%m
creditors - long creditors - long217.8838.86%269.0242.16%420.7041.35%421.3040.18%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL284.1450.67%335.4352.57%512.3050.36%539.4051.44%m
EQUITY
ord cap, reserves ord cap, reserves274.6348.98%301.0747.19%505.0049.64%509.1048.56%m
prefs, minorities prefs, minorities1.980.35%1.560.24%--%--%m
TOTAL276.6149.33%302.6447.43%505.0049.64%509.1048.56%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Dechra Pharmaceuticals Cash Flow Statement

30 Jun 2016 (GBP)30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)
Operating CF43.5877.4364.0081.80m
Pre-Financing CF-13.0520.15-177.7019.90m
Retained CF-5.1521.7416.10-0.20m

Dechra Pharmaceuticals Brokers

NameActivityTypeMnemonicCode
Commerzbank AGMarket Maker(MME)Broker/DealerKLWTDRESGB2LPST
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Investec Bank PlcMarket Maker(MME)Broker/DealerINV.IHCSGB21002
Morgan Stanley Securities LtdMarket Maker(MME)Broker/DealerMOSTMSSEGB21
Numis Securities LimitedMarket Maker(MME)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
DPH
Dechra Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191207 06:04:01